Grössmann, N. and Wild, C. and Nachtnebel, A. (2015): Horizon Scanning in Oncology: Results of the 25th Prioritisation – 4th quarter 2015. HSO: 25th Prioritisation.
|PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader|
For the 25th prioritisation (December 2015), 11 drugs were filtered out of 199 identified and were sent to prioritisation. Of these, 3 drugs were ranked as 'highly relevant' by the expert panel, 8 as 'relevant' and none as 'not relevant'. For 'highly relevant' drugs, further information including, for example, abstracts of phase III studies and licensing status is contained in this document.
|Item Type:||DSD: Horizon Scanning in Oncology|
|Subjects:||WB Practice of medicine > WB 300-962 Therapeutics|
QZ Pathology > QZ 200-380 Neoplasms.Cysts
|Series Name:||HSO: 25th Prioritisation|
|Deposited on:||27 Jan 2016 14:55|
|Last Modified:||02 Feb 2016 15:07|
Repository Staff Only: item control page